US Patent Issued to Chungbuk National University Industry-Academic Cooperation Foundation on Feb. 17 for "Use of PAK4 and CRTC1 for treatment or diagnosis of brain degenerative disease" (South Korean Inventors)

ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,553,882, issued on Feb. 17, was assigned to Chungbuk National University Industry-Academic Cooperation Foundation (Cheongju-si, South Korea).

"Use of PAK4 and CRTC1 for treatment or diagnosis of brain degenerative disease" was invented by Eung Gook Kim (Cheongju-si, South Korea), So Yoon Won (Cheongju-si, South Korea) and Eun Young Shin (Cheongju-si, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to use of PAK4 and CRTC1 or the treatment or diagnosis of a degenerative brain disease. Specifically, the present invention relates to a pharmaceutical composition for the prevention or treatment of a degenerative brain...